Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patientsXiaohang Qiao, Jacques Neefjes, Sabina Y. van der Zanden et al.|Molecular Cancer|2024Cited by 20